At a glance
- Originator Roche
- Class Immunotherapies; Macrolides
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunosuppression
Most Recent Events
- 21 Jul 1998 No-Development-Reported for Immunosuppression in Germany (Unknown route)
- 24 Jan 1995 Preclinical development for Immunosuppression in Germany (Unknown route)